SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...
The granting of emergency use authorization by the U.S. FDA to Roche AG for its four-in-one molecular test for SARS-CoV-2, Influenza A/B viruses and respiratory syncytial virus will allow the company ...
Accordingly, there is an ongoing market in antigen-based testing for this virus. Microbix's SARS-CoV-2 antigen QAPs support quality assessment needs related to such testing and comprise a meaningful ...
Many proteins have a complex architecture that enables biological functions. Molecules can bind to specific sites on a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results